DrugPatentWatch tracks the full patent portfolio associated with an NDA, including manufacturing process patents, pending patent applications, and continuation filings that have not yet issued none of which appear in the Orange Book
Lipid-based nanoparticles, including solid lipid nanoparticles and nanoemulsions, have demonstrated enhanced protection of SFN from degradation in the gastrointestinal tract, while polymeric nanoparticles such as PLGA-based systems enable sustained release profiles that maintain therapeutic concentrations over extended periods
Wagar, Ji Nature Reviews Bioengineering .2026
trial approval for HDM1002, an oral GLP-1 full agonist, demonstrating Chinas expanding international research collaborations and technological strength
Cholelithiasis in patients treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials
Clinical studies have demonstrated its effectiveness in inducing significant weight loss